At treatment end , HbA@c values and the proportion of participants with HbA@c < @ % ( < @mmol/mol ) were not significantly different for glargine -LSB- @ % ( @mmol/mol ) and @ % -RSB- versus NPH -LSB- @ % ( @mmol/mol ) and @ % -RSB- .